People · Operator
Named in public records as an officer, director or promoter · active 2026–2026 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Thrombolex, Inc. | — | Other Health Care | Series B | $55.6M | $129.3M | 2026 |
Sam A. Liang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sam A. Liang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marvin Woodall | 1 | 2 |
| Keegan A. Harper | 1 | 2 |
| Marvin J. Woodall | 1 | 1 |
| John J. Cerminaro | 1 | 1 |
| Clay A. DeMarcus | 1 | 1 |
| Michael J. Cerminaro | 1 | 1 |
| John A. Cerminaro | 1 | 1 |
| Kelly A. Elliott | 1 | 1 |
| Todd A. Richmond | 1 | 1 |
| Tony J. Litwiller | 1 | 1 |
| Brian G. Firth | 1 | 1 |
| David A. Bonita | 1 | 1 |
| John G. Cerminaro | 1 | 1 |
| Paul A. Stewart | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.